STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

RIGL RIGEL PHARMACEUTICALS INCORPORATED StockScouter® Report

3

StockScouter® Score

RIGEL PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive

 

Concerns

  • Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
  • One or more analysts has modestly decreased quarterly earnings estimates for RIGL. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 60% done.
Low
High

Core Model Grades

C
F
C
D

Previous Ratings

3
4
3